This summer, Omar Rodriguez, 47, was diagnosed with stage 3 colon cancer. And even though he had surgery to get rid of the tumor, there's a 70 percent possibility that it will return within the next five years.

The study, funded by the Prostate Cancer Foundation, found immune cells in prostate tissue could be activated to destroy cancer cells. The research was conducted by Dr Ellie-May Jarvis as part of her PhD with the Malaghan Institute in Wellington. It has been published in the medical journal Frontiers in Immunology.

Scientists have shown how a fatty acid found in palm oil can encourage the spread of cancer, in work that could pave the way for new treatments. The study, on mice, found that palmitic acid promoted metastasis in mouth and skin cancers. In future, this process could be targeted with drugs or carefully designed eating plans, but the team behind the work cautioned against patients putting themselves on diets in the absence of clinical trials.

Just a few hours a week of moderate exercise may reduce your risk of cancer, a new study suggests. If Americans got the recommended five hours a week of moderate-intensity physical activity, more than 46,000 cancer cases could be prevented in the United States each year, according to the report.

A new cancer treatment can wipe out tumours in terminally ill head and neck cancer patients, scientists have discovered. In a landmark trial, a cocktail of immunotherapy medications harnessed patients’ immune systems to kill their own cancer cells and prompted “a positive trend in survival”, according to researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS foundation trust.

Britain's state-run National Health Service will on Monday begin the world's biggest trial of Grail Inc's flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear.

Men who ejaculate more often have a lower risk of developing prostate cancer, a new study finds. Researchers from Harvard University analyzed data from nearly 32,000 men and found that ejaculating at least 21 times a month cut the risk of developing the cancer by one-third.

Researchers have successfully tested a "Trojan Horse" drug which can kill cancer and bacterial cells without damaging nearby healthy tissue. Scientists at the University of Edinburgh combined the tiny cancer-killing molecule SeNBD with a chemical food compound to trick malignant cells into ingesting it.

The vaccine for human papillomavirus (HPV) is recommended in the United States for all young people up to age 26 to help prevent certain deadly cancers.

Using ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agent

A team of researchers led by scientists at Tel Aviv University say they may have stumbled upon the “Achilles’ heel” of cancer cells, which could in the future lead to the development of an entirely new array of cancer drugs and treatments.

The future of cancer treatment might involve personalized vaccines meant to manage or even prevent relapses—at least if new research published Thursday continues to pan out. In a small clinical trial, high-risk melanoma patients given such a vaccine were able to create a long term, durable immune response to their cancer, scientists said. They also remained alive four years after the initial treatment, with most being actively disease-free.

The 10-year survival rate for cancer, once regarded as an incurable disease, has steadily been improving in Japan and if the cancer can be detected early enough, this survival rate increases further.

Scientists from the Tokyo University of Science say they have identified a polyphenolic compound found in blueberries called pterostilbene (PSB) with strong immunosuppressive properties. They believe it can provide a potential therapeutic option for chronic inflammatory diseases, including inflammatory bowel disease (IBD).

More than 200 genes with novel and known roles in glioblastoma – the most aggressive type of brain cancer – offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke’s Hospital and their collaborators engineered a new mouse model to show for the first time how a mutation in the well-known cancer gene, EGFR initiates glioblastoma, and works with a selection from more than 200 other genes to drive the cancer.

Sitting for hours on end could heighten someone's risk of later dying from cancer, according to a sobering new study of the relationship between inactivity and cancer mortality. The study was epidemiological, providing a snapshot of people's lives, so it cannot prove cause and effect. But the findings suggest that extremely sedentary people can be as much as 80 per cent more likely to die of cancer than those who sit the least.

Aspirin is associated with a reduction in the risk of developing several cancers of the digestive tract, including some that are almost invariably fatal, such as pancreatic and liver cancers. The largest and most comprehensive analysis to date of the link between aspirin and digestive tract cancers found reductions in the risk of these cancers of between 22% and 38%.